Exact Sciences NASDAQ EXAS
$43.05 -3.76 -8.73%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

7.51B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

9.39B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.31
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

174.42M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-44.69 %
Upcoming events Exact Sciences All events
No upcoming events scheduled

Stock chart Exact Sciences

Stock analysis Exact Sciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-10.07 17.08
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
2.22 4.27
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-17.81 10.93
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-3.57 -0.0200
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-22.88 16.46

Price change Exact Sciences per year

89.65$ 158.00$
Min Max

Summary analysis Exact Sciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Exact Sciences

Revenue and net income Exact Sciences

All parameters

About company Exact Sciences

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Address:
5505 Endeavor Lane, Madison, WI, United States, 53719
Company name: Exact Sciences
Issuer ticker: EXAS
ISIN: US30063P1057
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2001-02-01
Sector: Healthcare
Industry: Biotechnology
Site: https://www.exactsciences.com

On which stock exchange are Exact Sciences (EXAS) stocks traded?

Exact Sciences (EXAS) stocks are traded on NASDAQ.

What is the ticker of Exact Sciences stocks (EXAS)?

The stock ticker of Exact Sciences’s stocks or in other words, the code is EXAS. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Exact Sciences (EXAS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Exact Sciences (EXAS) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Exact Sciences (EXAS) stocks traded?

Exact Sciences (EXAS) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Exact Sciences (EXAS) stocks today?

The current price of Exact Sciences stocks on 10.08.2022 is 43.05 dollars. per share.

What is the dynamics of Exact Sciences (EXAS) stocks from the beginning of the year?

Exact Sciences (EXAS) quotes have increased by -47.19% from the beginning of the year up to 43.05 dollars. per 1 stocks.

How much did Exact Sciences (EXAS) stocks increase in августе 2022?

This month Exact Sciences (EXAS) quotes have increased by -8.81% to 43.05 dollars. per share.

How much are Exact Sciences (EXAS) stocks worth?

Today, on October, 10.08.2022 Exact Sciences’s (EXAS) stocks cost 43.05 dollars..

What is the market capitalization of Exact Sciences (EXAS)?

Capitalization is the market value of Exact Sciences (EXAS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 10.08.2022, the market capitalization of Exact Sciences (EXAS) is estimated at about 7508651850 dollars.